Enriching for Tumor-Reactive CD8 TIL with CD39/103 Markers: Implications for TIL Therapy

Time: 2:00 pm
day: Conference Day 1


  • CD39 and CD103 DP CD8 TIL highly enrich for tumor-specificity
  • Reactivity and recovery of function is associated with a 1-2 week incubation period
  • Discuss how these T cells represent a natural and diverse TCR repertoire to tumor antigens and can be found in most solid malignancies, although frequencies vary